TRDA Competitors & Alternatives
Compare Entrada Therapeutics Inc with similar stocks in the same industry
Biotechnology
TRDA
Main Stock$6.80
Tradestie Score
48
Market Cap
$223.66M
Revenue Growth
-0.5%
Analyst Upside
+179.4%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OMER
Omeros Corporation
|
$18.28
|
$281.75M | 11.8 | 41 | Compare |
|
DBVT
DBV Technologies S.A.
|
$11.85
|
$275.54M | - | 38 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.78
|
$275.13M | - | 46 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$22.30
|
$269.08M | 0.1 | 47 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.21
|
$262.67M | - | 48 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$35.48
|
$256.54M | - | 43 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$13.02
|
$240.89M | - | 55 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.07
|
$231.77M | - | 42 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$10.88
|
$227.00M | - | 47 | Compare |
More TRDA Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry